CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Amed Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Amed Co Ltd
4F
No.14, Wuquan 7th Road, Wugu District
Phone: +886 222989952p:+886 222989952 NEW TAIPEI, 248  Taiwan Ticker: 75757575

Business Summary
Amed Co Ltd is a Taiwan-based company mainly engaged in medical-related business. The Company's business is divided into three main platforms: the wound care platform, which aims to provide comprehensive solutions for wounds; the pain-free medical platform, which aims to enable patients to reduce or eliminate pain after surgery and achieve rapid recovery and early discharge; and the medical device support platform, which aims to use innovative medical devices to simplify clinical diagnosis or treatment support. The main products of the wound care platform are high-end wound dressings; the main products of the pain-free medical platform are long-lasting pain relief injections; and the products of the medical device support platform include artificial blood vessels and other medical materials. The Company sells its products domestically and internationally.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer, General Manager YaoqianWang 11/20/2023
Independent Director YiqiLi 5/31/2023 5/31/2023

General Information
Outstanding Shares: 30,000,000 (As of 8/24/2023)
Stock Exchange: TPO
Fax Number: +886 222981772


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024